| Jervois Global Limited (JRV) ORDINARY FULLY PAID |
Materials |
$30 |
Extension of Waivers and ICO Bond Interest Deferral
|
2 Sep 2024 8:46AM |
$0.012 |
$0.011 |
fallen by
8.33%
|
|
JRV - Price-sensitive ASX Announcement
Full Release
Key Points
- Jervois Global Limited has extended the current Waiver and Interest Deferral of the Idaho Cobalt Operations (ICO) Bonds to 6 September 2024.
- The Holder is the majority bondholder of the US$100 million 12.5% ICO senior secured bonds and sole lender for the Jervois Finland Working Capital Facility.
- The extended waiver covers all financial covenants and certain potential cross-defaults associated with the ICO Bonds.
- At least 2/3 of the principal amount of the ICO Bonds required for the Waiver and Deferral implementation has been approved by the bondholders.
- Jervois is working with debt and equity capital providers and third parties on transactions to strengthen its balance sheet.
- There are no changes proposed to the terms of the ICO Bonds besides the Waiver and the Deferral.
- The announcement includes a caution that forward-looking statements are based on assumptions and subject to significant risks and uncertainties.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian Clinical Labs Limited (ACL) ORDINARY FULLY PAID |
Health Care |
$624 |
Appointment of CFO
|
2 Sep 2024 8:45AM |
$3.000 |
$3.140 |
risen by
4.67%
|
|
| Poseidon Nickel Limited (POS) ORDINARY FULLY PAID |
Materials |
- |
Windarra Tailings Project and Water Access Agreement Update
|
2 Sep 2024 8:45AM |
$0.004 |
$0.006 |
risen by
37.50%
|
|
POS - Price-sensitive ASX Announcement
Full Release
Key Points
- Poseidon Nickel Limited terminated its agreement with Mt Morgans WA Mining.
- The termination was due to unmet conditions precedent.
- The agreement with Encore Minerals for the Windarra Tailings Project remains unaffected.
- Encore Minerals will use proprietary Glycine Leaching Technology for processing.
- Poseidon Nickel focuses on nickel sulphide exploration and development in Western Australia.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Green Critical Minerals Limited (GCM) ORDINARY FULLY PAID |
Materials |
$22 |
Proposed issue of securities - GCM
|
2 Sep 2024 8:45AM |
$0.003 |
$0.011 |
risen by
340%
|
|
| Green Critical Minerals Limited (GCM) ORDINARY FULLY PAID |
Materials |
$22 |
Proposed issue of securities - GCM
|
2 Sep 2024 8:44AM |
$0.003 |
$0.011 |
risen by
340%
|
|
| Elanor Investor Group (ENN) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Consumer Discretionary |
$125 |
Change of Director's Interest Notice
|
2 Sep 2024 8:44AM |
$0.820 |
$0.820 |
fallen by
0%
|
|
| Imugene Limited (IMU) ORDINARY FULLY PAID |
Health Care |
$179 |
Three Complete Responses in Azer-Cel Phase 1b Trial
|
2 Sep 2024 8:44AM |
$0.062 |
$0.024 |
fallen by
61.29%
|
|
IMU - Price-sensitive ASX Announcement
Full Release
Key Points
- Imugene Limited announced promising results from its Phase 1b clinical trial with azer-cel in patients with relapsed/refractory diffuse large B cell lymphoma (DLBCL).
- The first 2 patients in Cohort B achieved complete responses and continue to maintain their complete responses for over 120 days and over 90 days.
- All four patients in Cohort B failed 4 to 5 prior treatments, including autologous CAR T therapy, yet remain on the study.
- Of the 6 evaluable patients in Cohort A, 1 achieved a complete response and 1 had a partial response, resulting in an overall response rate of 33%.
- Of the 3 evaluable patients in Cohort B, 2 achieved complete responses, resulting in an overall response rate of 67%.
- The trial is being conducted across 15 cancer centers in the U.S. with plans to expand to up to 5 sites in Australia.
- The study results suggest improved outcomes when IL-2 is added to the azer-cel regimen.
- The safety and tolerability of azer-cel have been confirmed in the study.
- The company aims to provide an interim Phase 1b data update and is preparing for a potential FDA Phase 2/3 registrational trial.
- Azer-cel has the potential to become the first approved allogeneic CAR T cell therapy for blood cancer.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| FleetPartners Group Limited (FPR) ORDINARY FULLY PAID |
Financials |
$629 |
Update - Notification of buy-back - FPR
|
2 Sep 2024 8:44AM |
$3.190 |
$2.800 |
fallen by
12.23%
|
|
| Ausquest Limited (AQD) ORDINARY FULLY PAID |
Materials |
$89 |
RRS Conference MD to Present
|
2 Sep 2024 8:44AM |
$0.011 |
$0.066 |
risen by
500%
|
|
| Ryder Capital Limited (RYD) ORDINARY FULLY PAID |
Financials |
$104 |
Update - Notification of buy-back - RYD
|
2 Sep 2024 8:44AM |
$1.150 |
$1.270 |
risen by
10.43%
|
|
| Wisetech Global Limited (WTC) ORDINARY FULLY PAID |
Information Technology |
$29,513 |
Company appointments
|
2 Sep 2024 8:44AM |
$118.870 |
$88.215 |
fallen by
25.79%
|
|
| EnviroSuite Limited (EVS) ORDINARY FULLY PAID |
Information Technology |
$101 |
Notification - Investor briefing
|
2 Sep 2024 8:43AM |
$0.045 |
$0.070 |
risen by
55.56%
|
|
| Raiden Resources Limited (RDN) ORDINARY FULLY PAID |
Materials |
$17 |
Key tenement granted on Andover South Project
|
2 Sep 2024 8:42AM |
$0.026 |
$0.005 |
fallen by
80.77%
|
|
RDN - Price-sensitive ASX Announcement
Full Release
Key Points
- Key tenement on Andover South Project, E47/4062, has been granted
- Programme of Work (PoW) for diamond drilling on E47/4062 has been submitted to DEMIRS for approval
- Drilling and earthmoving contractor contracts under final review and anticipated to be awarded soon
- Diamond drilling program will commence as soon as PoW is approved and contractors mobilise to site
- Transfer between Welcome Exploration Pty Ltd and Raiden for the Company's 80% interest will occur
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Terra Uranium Limited (T92) ORDINARY FULLY PAID |
Energy |
$3 |
Update - Proposed issue of securities - T92
|
2 Sep 2024 8:41AM |
$0.069 |
$0.031 |
fallen by
55.07%
|
|
| Regener8 Resources NL (R8R) ORDINARY FULLY PAID |
Materials |
$4 |
Activities Advance Prior to Maiden Drilling at East Ponton
|
2 Sep 2024 8:41AM |
$0.100 |
$0.120 |
risen by
20%
|
|
R8R - Price-sensitive ASX Announcement
Full Release
Key Points
- Cultural Heritage survey completed at Grasshopper and Hatlifter prospects.
- Program of Works (POW) approvals received from DEMIRS.
- Exploration planning underway.
- Anticipate maiden drilling in Q4 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bio-Gene Technology Ltd (BGT) ORDINARY FULLY PAID |
Materials |
$5 |
Bio-Gene & Rallis achieve key Flavocide production milestone
|
2 Sep 2024 8:40AM |
$0.044 |
$0.026 |
fallen by
40.91%
|
|
BGT - Price-sensitive ASX Announcement
Full Release
Key Points
- Successful pilot-scale production of Flavocide® by Rallis India Limited
- Consistent quality and yield achieved at pre-commercial scale
- Flavocide® production to support regulatory approval and future supply
- Bio-Gene’s proprietary synthesis process validated
- Production milestone reduces technical risk for commercial quantities
- Rallis India’s expertise and facilities critical in the process
- Flavocide® addresses insecticide resistance with a new mode of action
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Elanor Investor Group (ENN) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Consumer Discretionary |
$125 |
Notification of cessation of securities - ENN
|
2 Sep 2024 8:40AM |
$0.820 |
$0.820 |
fallen by
0%
|
|
| Zip Co Limited (ZIP) ORDINARY FULLY PAID |
Financials |
$2,265 |
2024 Annual General Meeting
|
2 Sep 2024 8:40AM |
$2.400 |
$1.735 |
fallen by
27.71%
|
|
| Globe Metals & Mining Limited (GBE) ORDINARY FULLY PAID |
Materials |
$18 |
Globe announces offtake LOI for Kanyika Phase 1 production
|
2 Sep 2024 8:40AM |
$0.037 |
$0.026 |
fallen by
29.73%
|
|
| Praemium Limited (PPS) ORDINARY FULLY PAID |
Information Technology |
$356 |
Update - Notification of buy-back - PPS
|
2 Sep 2024 8:39AM |
$0.545 |
$0.745 |
risen by
36.70%
|
|
| Lifestyle Communities Limited (LIC) ORDINARY FULLY PAID |
Real Estate |
$875 |
Final Director's Interest Notice
|
2 Sep 2024 8:38AM |
$7.720 |
$7.190 |
fallen by
6.87%
|
|
| Centrex Limited (CXM) ORDINARY FULLY PAID |
Materials |
$15 |
Ardmore Operations Update
|
2 Sep 2024 8:37AM |
$0.030 |
$0.017 |
fallen by
43.33%
|
|
| Dart Mining NL (DTM) ORDINARY FULLY PAID |
Materials |
$3 |
Expiry of Unlisted Options
|
2 Sep 2024 8:37AM |
$0.020 |
$0.005 |
fallen by
75%
|
|
| Energy One Limited (EOL) ORDINARY FULLY PAID |
Information Technology |
$388 |
Notification of cessation of securities - EOL
|
2 Sep 2024 8:37AM |
$4.560 |
$12.400 |
risen by
171.93%
|
|
| Provaris Energy Ltd (PV1) ORDINARY FULLY PAID |
Energy |
$8 |
Study reaffirms compressed H2 for low cost supply
|
2 Sep 2024 8:37AM |
$0.022 |
$0.012 |
fallen by
45.45%
|
|
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
